Skip to content

News & Media
Contact us

News & Media
Contact us

Disease Area
Science & Innovation
Our Scientists
Pipeline
Partnership Portal
Investors
Patents
About us

Disease Area
Science & Innovation
Our Scientists
Pipeline
Partnership Portal
Investors
Patents
About us

Dawn Therapeutics Announces New Preclinical Data for DTX-101

By adehkordi / 20 August 2025

Targeted Lentiviral Vectors for CNS and Musculoskeletal Disorders

About

About Us
Our Scientists
Careers
Contact US

Science

Science & Platform
Pipeline
Publications & Resources
Clinical Trials Hub

Stakeholders

Patients & Families
Medical Professionals
Partnering
Investors

News

Newsroom
Events
Responsibility & ESG
Community

Compliance

Compliance
Privacy Policy
Cookie Policy & Settings
Terms of Use
Accessibility Statement

Copyright © 2026 DawnTherapeutics.com. All Rights Reserved.

Facebook Twitter Youtube

Scroll to Top